NCT07714421 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07714421
Title	Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
Recruitment	Not yet recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Jonsson Comprehensive Cancer Center
Indications	primary mediastinal B-cell lymphoma high-grade B-cell lymphoma double-hit/triple-hit diffuse large B-cell lymphoma follicular lymphoma
Therapies	Cyclophosphamide + Doxorubicin + Epcoritamab-bysp + Polatuzumab vedotin-piiq + Prednisone + Rituximab Epcoritamab-bysp + Polatuzumab vedotin-piiq + Rituximab Epcoritamab-bysp
Age Groups:	senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
UCLA / Jonsson Comprehensive Cancer Center		Los Angeles	California	90095	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07714421Clinical Trial Detail